The average hazard ratio over 12 months is 0.81, indicating an increasing treatment benefit, though the corresponding hypothesis test is not yet significant with a p‐value of 0.063.
← all excerpts
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional Hazards.
1
—
—